Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01775267 · ClinicalTrials.gov registry record · Phase 2
ALLPS VERSUS PVO Randomized Controlled Trial
A Phase 2 study, sponsored by University of Zurich.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT01775267 is a Phase 2 study that was terminated before completion, run by University of Zurich. The registered enrollment target is 7 participants.
The verdict
NCT01775267, a Phase 2 study, was terminated before completion, sponsored by University of Zurich.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
This randomized phase II trial compares how well associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) or portal vein occlusion (PVO) works in treating patients with liver cancer. Both treatments are types of 2-stage hepatectomies for removing liver cancer. ALPPS may be more effective than PVO in patients whose disease would traditionally be considered inoperable. * Trial with surgical intervention
Interventions
- PROCEDURE Associating liver partition and portal vein ligation for staged hepatectomy
- PROCEDURE Portal vein embolization or ligation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01775267
The ClinicalTrials.gov registry entry for NCT01775267 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Zurich, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Associating liver partition and portal vein ligation for staged hepatectomy is the first listed.
NCT01775267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01775267 about?
NCT01775267 is a clinical study titled "ALLPS VERSUS PVO Randomized Controlled Trial". This randomized phase II trial compares how well associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) or portal vein occlusion (PVO) works in treating patients with liver cancer. Both treatments are types of 2-stage hepatectomies for removing liver cancer. ALPPS may b...
What is the current status of trial NCT01775267?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2012-11. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01775267?
The interventions under investigation include: Associating liver partition and portal vein ligation for staged hepatectomy (PROCEDURE), Portal vein embolization or ligation (PROCEDURE).
Who is sponsoring clinical trial NCT01775267?
This trial is sponsored by University of Zurich, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.